Psychiatric Drugs Explained - Elsevier E-Book on VitalSource (Retail Access Card), 7th Edition

by David Healy, MD, FRCPsych

Elsevier eBook on VitalSource - Access Card

ISBN: 9780702083938

Publication Date: 05-24-2022

Page Count: 356

Imprint: Elsevier

List Price: $28.99

Important note

Please note

This item has low stock levels and may be back-ordered. We'll let you know if it is back-ordered, and you will not be charged until the item ships.

Technical Support

Contact your Elsevier Sales Rep to learn more about adopting this product

Psychiatric Drugs Explained offers a wealth of evidence-based information on psychiatric drugs in an easy-to-use format that can be quickly referenced in the clinical setting. Written by internationally recognised author Dr David Healy, the book provides a comprehensive review of drug effects, action and side-effects. There is an emphasis on the lived experience of patients, providing the reader with a sense of what the adverse effects of drugs might feel like to those who use them. A reader-friendly approach and clear layout, with information organised by disorder, make this popular title accessible and useful not only to nursing staff, but to all members of the multidisciplinary team.

Related Products
Key Features
- Quick reference guide suitable for all members of the multidisciplinary team
- Helpful boxes on user issues make potential complications easy to spot
- Distinctive, reader-friendly style helps the reader understand the benefits and impacts of psychotropic drugs
- New topics include management of dependence disorders, stimulants and drugs for children, cognitive impairment and sleep disorders
- The only book with detailed coverage of the sexual side effects of psychiatric drugs and the abusive prescribing of prescription drugs
Contents

Section 1 Management of the psychoses
1 The antipsychotics
2. Antipsychotic side effects and their management

Section 2 Management of depression
3. The antidepressants
4. Side effects of antidepressants

Section 3 Management of bipolar disorders
5. Management of acute bipolar disorder
6. Mood-stabilisers

Section 4 Stimulants & Drugs for children
7. Stimulants & Drugs for children

Section 5 Management of anxiety
8. The anxiety disorders
10. Benzodiazepine anxiolytics
11. Anxiolysis and the serotonin system
12. Beta-blockers and anxiety

Section 6 Management of sleep disorders and insomnia
13. Sleep disorders and insomnia
14. Non-pharmacological management of insomnia
15. Hypnotics
16. Sedatives

Section 7 Management of cognitive impairment
17. Cognitive enhancement and the dementias
18. Cognitive enhancement and neuroprotection

Section 8 Management of sexual difficulties
19. The range of sexual difficulties
20. Effects of drugs on aspects of sexual functioning

Section 9 Management of dependence and withdrawal
21. Dependence & Withdrawal
22. Dependence & Craving
23. Dependence & Protracted Withdrawal

Section 10 Consent, abuse and liability
24. Consent
25. Pharmacological abuse

Section 11 The marketing of tranquillity
26. The ethical industry
27. Evidence-biased care
28. Marketing & Risk
29. From healthcare to pharmageddon
Authors

David Healy, MD, FRCPsych, Director, North Wales Department of Psychological Medicine, College of Medicine, Cardiff University, Bangor, UK